« Back to Record
Citation APA

Millot, F., Suciu, S., Philippe, N., Benoît, Y., Mazingue, F., Uyttebroeck, A., Lutz, P., Mechinaud, F., Robert, A., Boutard, P., Marguerite, G., Ferster, A., Plouvier, E., Rialland, X., Behard, C., Plantaz, D., Dresse, M.-F., Philippet, P., Norton, L., Thyss, A., Dastugue, N., Waterkeyn, C., Vilmer, E., Otten, J., & Children's Leukemia Cooperative Group of the European Organiztaion for Research and Treatment of Cancer, (2001). Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial. Journal of clinical oncology, 19(7), 1935-1942.


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/96521

Millot, F., Suciu, S., Philippe, N., Benoît, Y., Mazingue, F., Uyttebroeck, A., Lutz, P., Mechinaud, F., Robert, A., Boutard, P., Marguerite, G., Ferster, A., Plouvier, E., Rialland, X., Behard, C., Plantaz, D., Dresse, M.-F., Philippet, P., Norton, L., Thyss, A., Dastugue, N., Waterkeyn, C., Vilmer, E., Otten, J., & Children's Leukemia Cooperative Group of the European Organiztaion for Research and Treatment of Cancer, (2001). Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial. Journal of clinical oncology, 19(7), 1935-1942.